McDowell Caryn Gordon 4
4 · Revance Therapeutics, Inc. · Filed Jan 2, 2019
Insider Transaction Report
Form 4
McDowell Caryn Gordon
SVP, GC & Secretary
Transactions
- Other
Common Stock
2018-12-31$17.11/sh+818$13,996→ 16,818 total
Footnotes (1)
- [F1]These shares were acquired by Ms. McDowell under the Issuer's 2014 Employee Stock Purchase Plan on December 31, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).